USE OF REAL-WORLD EVIDENCE IN EUROPEAN MEDICINES AGENCY DECISIONS

被引：0
|
作者：
Watson, C. [1 ]
Jones, G. [1 ]
Shaw, C. [1 ]
机构：
[1] PHMR Ltd, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P33
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [42] Use of real-world evidence in translational pharmacology research
    Charveriat, Mathieu
    Darmoni, Stephan J.
    Lafon, Vincent
    Moore, Nicholas
    Bordet, Regis
    Veys, Julien
    Mouthon, Franck
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (02) : 230 - 236
  • [43] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
  • [44] Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
    Pearson, Sallie-Anne
    Pratt, Nicole
    de Oliveira Costa, Juliana
    Zoega, Helga
    Laba, Tracey-Lea
    Etherton-Beer, Christopher
    Sanfilippo, Frank M.
    Morgan, Alice
    Kalisch Ellett, Lisa
    Bruno, Claudia
    Kelty, Erin
    IJzerman, Maarten
    Preen, David B.
    Vajdic, Claire M.
    Henry, David
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [45] Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
    Rose, Klaus
    Walson, Philip D.
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 253 - 265
  • [46] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [47] European Medicines Agency
    Camarero, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S38 - S39
  • [48] USE OF REAL-WORLD DATA IN REGULATORY AND REIMBURSEMENT SUBMISSIONS FOR PERSONALIZED MEDICINES IN EUROPE
    Chagneau, C.
    Bianic, F.
    Guelfucci, F.
    Sysavath, C.
    Vossen, C.
    VALUE IN HEALTH, 2022, 25 (12) : S270 - S270
  • [49] Use of medicines in special conditions: Real-world treatment outcomes in a tertiary hospital
    Giraldo Pena, A.
    Munoz Bolano, M.
    Rodriguez Cumplido, D.
    Ruiz Batuecas, E.
    Comas Sugranes, M.
    Ferrer Artola, A. M.
    Llop Rius, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 51 - 51
  • [50] Use of Real-World Data for the Research, Development, and Evaluation of Oncology Precision Medicines
    Lewis, Jan R. R.
    Kerridge, Ian
    Lipworth, Wendy
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 11
12345